missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CNR2 Recombinant Rabbit Monoclonal Antibody (HL3120)

Description
CNR2 Recombinant Monoclonal Antibody for Western Blot
Cannabinoids exert their well known physiological effects through two G protein coupled receptors, cannabinoid receptor 1 (CB1) and CB2. Both cannabinoid receptors have been shown to inhibit adenylyl cyclase as well as stimulate the mitogen-activated protein kinase, MAPK. CB1 receptors also modulate ion channels through direct G-protein interactions. Delta 9-tetrahydrocannibinol and related ligands likely exert their psychoactive effects by inhibiting presynaptic N- and P/Q type calcium channels. CB2 is thought to function primarily in the immune system although it has been suggested to be present in the central nervous system, including the retina.
Specifications
Specifications
| Antigen | CNR2 |
| Applications | Western Blot |
| Classification | Recombinant Monoclonal |
| Clone | HL3120 |
| Concentration | 2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with no preservative |
| Gene | CNR2 |
| Gene Accession No. | P34972 |
| Gene Alias | Cannabinoid Receptor 2; cannabinoid receptor 2 (macrophage); CB2; CB-2; CB2 receptor; CB2A; CB2B; CB2C; CB2R; CB2-R; CNR2; CNR2C; CNR3; CX5; HCB2; HGNC:2160; OTTHUMP00000044841; peripheral cannabinoid receptor; rCB2; RP11-4M23.1; testis-dominant CNR2 isoform CB2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?